Topics:

All Content

It’s time to rethink aspirin; there’s optimism about the PCSK9 inhibitors; and new help for people with valvular heart disease. What else is new in cardiology?

(Courtesy David Schwartz, MD)

There is a lot of new information about the link between various malignancies and inflammatory bowel disease. Here: answers to 3 key questions.

I’ll admit I was a little nervous to attend the annual American College of Physicians (ACP) meeting this year, what with the MOC snafu and the fall out.

Novel oral anticoagulant myths debunked

No monitoring necessary; don't use them before electrical cardioversion; and count them out for periprocedural use during AF ablation. Really?

Guidelines say “no” to anticoagulation for young, otherwise healthy persons with atrial fibrillation. New research finds that clinical practice looks quite different.

Pamela Wible, MD, will stop taking commercial insurance on 6/1/2015. She gave her patients the option to leave or stay.

Heart scans to ID stroke risk, insomnia reduces quality of life, air pollution may be a cause, women think of stroke as a man’s disease—see these and other developments in stroke science and patient care.

Ablation therapy may be an option for these two patients with heart disease. What is your recommendation? And, does the evidence support it?

What brings patients to your office—and not the specialty office down the street? Insights in this slideshow.

The ADA provides an abridged version for PCPs of its annual Standards of Medical Care. Our slides summarize 6 updates important to primary care.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.